Clinical Trial Update: A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of ZYT1 in healthy volunteers; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Obesity

Drugs mentioned

• ZYT1

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Obesity, Lipid Disorders | Phase 1 | Status: TERMINATED